Financials

  • Market Capitalization 1.78 B
  • Employee 130
  • Founded 2019
  • CEO N/A
  • Website www.septerna.com
  • Headquarter Delaware, United States
  • FIGI BBG014WY1V28
  • Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-63.19
주가매출액비율
15.2

Related tickers

#이름가격24h %7d %1M %1Y %마켓 캡이전 7일
2070
TSHA
Taysha Gene Therapies, Inc. - Common Stock
5.56 USD-3.64%-7.33%-5.60%+91.72%1.81 B USD
2079
RXRX
Recursion Pharmaceuticals, Inc. - Class A Common Stock
3.35 USD+0.30%+2.45%+10.56%-27.02%1.79 B USD
2094
NTLA
Intellia Therapeutics, Inc. - Common Stock
12.54 USD-2.56%+0.64%+18.41%-8.60%1.76 B USD
2104
GHRS
GH Research PLC - Ordinary Shares
27.94 USD-2.48%-0.92%-0.82%+97.32%1.73 B USD